Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c (Q28508569)

24 January 2017

title

Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c (English)

1 reference

Myocyte enhancer factor 2C

24 January 2017

main subject

1 reference

GOA release 2020-03-11

author name string

Sandra Stehling-Sun

1

1 reference

24 January 2017

Jessica Dade

2

1 reference

24 January 2017

Stephen L. Nutt

3

1 reference

24 January 2017

Rodney P. DeKoter

4

1 reference

24 January 2017

Fernando D. Camargo

5

1 reference

24 January 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

24 January 2017

1 reference

24 January 2017

volume

10

1 reference

24 January 2017

issue

3

1 reference

24 January 2017

page(s)

289–296

1 reference

The Ikaros gene is required for the development of all lymphoid lineages

24 January 2017

cites work

1 reference

Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors

21 April 2017

1 reference

MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines

21 April 2017

1 reference

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C

21 April 2017

1 reference

MEF2C transcription factor controls chondrocyte hypertrophy and bone development

21 April 2017

1 reference

Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins

21 April 2017

1 reference

The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate

21 April 2017

1 reference

E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo

21 April 2017

1 reference

Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha

21 April 2017

1 reference

Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

21 April 2017

1 reference

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

21 April 2017

1 reference

Inducible gene targeting in mice

21 April 2017

1 reference

Evolving views on the genealogy of B cells

21 April 2017

1 reference

Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow

21 January 2018

1 reference

Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

21 January 2018

1 reference

The importance of PU.1 concentration in hematopoietic lineage commitment and maturation

21 January 2018

1 reference

Transcriptional regulation of lymphocyte development

21 January 2018

1 reference

Towards understanding skeletal muscle regeneration

21 January 2018

1 reference

Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.

21 January 2018

1 reference

Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis

21 January 2018

1 reference

Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes

21 January 2018

1 reference

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

21 January 2018

1 reference

Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development

21 January 2018

1 reference

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

21 January 2018

1 reference

A common pathway for dendritic cell and early B cell development.

21 January 2018

1 reference

PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis

21 January 2018

1 reference

Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality

21 January 2018

1 reference

Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.

21 January 2018

1 reference

Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer

21 January 2018

1 reference

PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors

21 January 2018

1 reference

E2A proteins promote development of lymphoid-primed multipotent progenitors

21 January 2018

1 reference

Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors

21 January 2018

1 reference

Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.

21 January 2018

1 reference

Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter

21 January 2018

1 reference

Hematopoietic stem cells do not engraft with absolute efficiencies

21 January 2018

1 reference

Regulation of B lymphocyte and macrophage development by graded expression of PU.1.

21 January 2018

1 reference

Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice

21 January 2018

1 reference

Requirement of the MADS-box transcription factor MEF2C for vascular development

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169261

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169261

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19169261